Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvation Bio, Inc.

3.49
-0.4100-10.51%
Pre-market: 3.41-0.0800-2.29%06:15 EDT
Volume:14.58M
Turnover:50.21M
Market Cap:1.19B
PE:-5.55
High:3.83
Open:3.82
Low:3.20
Close:3.90
52wk High:4.09
52wk Low:1.54
Shares:342.27M
Float Shares:231.05M
Volume Ratio:1.59
T/O Rate:6.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6288
EPS(LYR):-2.1131
ROE:-44.84%
ROA:20.17%
PB:3.20
PE(LYR):-1.65

Loading ...

Nuvation Bio Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
Aug 05

Nuvation Bio Unveils Promising Phase 2 Data for FDA-Approved IBTROZI™ in Advanced ROS1+ Lung Cancer at Upcoming WCLC and ESMO Congresses

Reuters
·
Aug 05

Nuvation Bio Inc. to Report Second Quarter 2025 Financial Results

Reuters
·
Jul 25

Nuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025

THOMSON REUTERS
·
Jul 25

Nuvation Bio Inc. Unveils Presentation Highlighting Advances in Oncology Treatments and Innovative Drug Developments

Reuters
·
Jul 17

2 Beaten-Down Biotech Stocks Just Saw Big Insider Buys -- Barron's

Dow Jones
·
Jul 05

Two Beaten-Down Biotech Stocks See Big Insider Buys -- Barrons.com

Dow Jones
·
Jun 29

Nuvation Bio Price Target Maintained With a $6.00/Share by JMP Securities

Dow Jones
·
Jun 25

Sector Update: Health Care Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Jun 24

Kerry Wentworth, Chief Regulatory Officer, Reports Acquisition of Nuvation Bio Inc. Common Shares

Reuters
·
Jun 19

Nuvation Bio Is Maintained at Outperform by RBC Capital

Dow Jones
·
Jun 17

RBC Cuts Price Target on Nuvation Bio to $6 From $10, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Jun 17

US Pharma Bets Big on China to Snap up Potential Blockbuster Drugs

Reuters
·
Jun 17

Nuvation Bio Down Over 17%, on Track for Record Percent Decrease -- Data Talk

Dow Jones
·
Jun 13

BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Cardinal Health, Adobe

Reuters
·
Jun 13

Nuvation Bio Is Maintained at Outperform by Wedbush

Dow Jones
·
Jun 12

Nuvation Bio Inc. Unveils Presentation on Global Oncology Innovations and Drug Development Progress

Reuters
·
Jun 12

Nuvation Bio Stock Trading Halted, Pending Material News Release

MT Newswires Live
·
Jun 12

BRIEF-FDA Approves Taletrectinib For ROS1-Positive Non-Small Cell Lung Cancer

Reuters
·
Jun 12

Nuvation Bio Inc. Conducted Annual Stockholders Meeting

Reuters
·
May 24